Non-small cell lung cancer (NSCLC) make up 80-85% of lung cancers, and responds poorly to current chemotherapeutics, making survival rates very low.
Dr. Honglin Luo and her team were recently awarded funding from the BC Lung Association to study how viruses can be used to treat lung cancer. The team found that Coxsackievirus B3 (CVB3) preferentially infects and destroys actively dividing cells (such as cancer cells) and stimulates immune processes within the host to further clear tumours from the body. The team will now test whether CVB3 can be used to effectively treat lung cancer in animal models. Results from this study could open doors to new treatments for NSCLC and other cancer types, improving survival rates for these devastating diseases.
Read more: https://bc.lung.ca/dr-honglin-luo